Question · asked by 1 review
Angiotensin‐converting enzyme inhibitors vs ARB: Cardiovascular events
- Population
- adults with early (stage 1 to 3) non‐diabetic CKD
- Intervention
- Angiotensin‐converting enzyme inhibitors
- Comparison
- ARB
- Outcome
- Cardiovascular events
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Angiotensin‐converting enzyme inhibitors vs angiotensin receptor blockers CVD events · adults with early (stage 1 to 3) non‐diabetic CKD The review found no eligible studies for this question. Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to… (2023) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non‐diabetic chronic… 2023 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Angiotensin‐converting enzyme inhibitors vs ARB · people with primary hypertension · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.